Home > Journals > Minerva Endocrinologica > Past Issues > Minerva Endocrinologica 2018 March;43(1) > Minerva Endocrinologica 2018 March;43(1):1-10

CURRENT ISSUE
 

ARTICLE TOOLS

Publication history
Reprints
Cite this article as

MINERVA ENDOCRINOLOGICA

A Journal on Endocrine System Diseases


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,383


eTOC

 

ORIGINAL ARTICLE  


Minerva Endocrinologica 2018 March;43(1):1-10

DOI: 10.23736/S0391-1977.17.02610-4

Copyright © 2017 EDIZIONI MINERVA MEDICA

language: English

Tumor and normal thyroid spheroids: from tissues to zebrafish

Valentina CIRELLO 1, 2 , Germano GAUDENZI 3, Elisa S. GRASSI 1, Carla COLOMBO 2, Leonardo VICENTINI 4, Stefano FERRERO 5, 6, Luca PERSANI 1, 3, Giovanni VITALE 1, 3, Laura FUGAZZOLA 1, 2

1 Division of Endocrine and Metabolic Diseases, Laboratory of Endocrine and Metabolic Research, Istituto Auxologico Italiano, Milan, Italy; 2 Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy; 3 Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy; 4 Endocrine Surgery Unit, Ca’ Granda Foundation and Institute for Research and Care, Milan, Italy; 5 Division of Pathology, Ca’ Granda Foundation and Institute for Research and Care, Milan, Italy; 6 Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy


PDF  


BACKGROUND: Multicellular spheroids represent an interesting experimental model with promising applications in the pre-clinical studies on anticancer drugs. We recently demonstrated that thyroid spheroids recapitulate the features of the original tissues, in either the differentiated and “stem-like” components. Here we were aimed to characterize thyroid spheroids and to investigate in vivo the proangiogenic potential of patient-derived xenografts (PDX) of spheroids obtained from papillary thyroid cancer (PTC) and the matched normal tissues.
METHODS: Spheroids cultures were obtained from 11 PTCs and matched normal tissues and characterized by immunohistochemistry. The expression of p53, involved in the regulation of stem cell homeostasis, was evaluated. The proangiogenic effect of thyroid spheroids was assessed by the injection in zebrafish embryos.
RESULTS: Thyroid spheroids are enriched in stem-like cells, as shown by the positivity for the stem cell marker OCT4, and by the low level of p53 expression. Interestingly, PTCs and normal thyroid tissues have a detectable p53 expression, whereas the derived spheroids are mainly constituted by cells that express p53 at a lower level. Finally, we show that PDXs derived from PTC or normal spheroids stimulate the migration and the growth of sprouting vessels toward the implant into the zebrafish embryos.
CONCLUSIONS: We report the characterization of multicellular spheroids obtained from PTCs and normal thyroid tissues, showing that they are enriched in stem-like cells. Moreover, we established xenografts of spheroids in zebrafish, demonstrating that they stimulate neoangiogenesis. This in vivo model could be considered as a valuable platform to test the effects of anticancer drugs.


KEY WORDS: Cellular spheroids - Thyroid neoplasms - Tumor suppressor protein p53 - Zebrafish - Heterografts

top of page

Publication History

Issue published online: January 11, 2018
Article first published online: January 31, 2017

Cite this article as

Cirello V, Gaudenzi G, Grassi ES, Colombo C, Vicentini L, Ferrero S, et al. Tumor and normal thyroid spheroids: from tissues to zebrafish. Minerva Endocrinol 2018;43:1-10. DOI: 10.23736/S0391-1977.17.02610-4

Corresponding author e-mail

valentina.cirello@unimi.it